Andrew Marion, Jeff Whitmore | GenomeWeb
Biomarker diagnostics developer Singulex has added Andrew Marion to its board of directors, the company said last week.
 
Marion is the founder of Applied Biosystems. He is currently a director at Molecular Devices, Applied Imaging, Alpha M.O.S., and Guava Technologies.
 
He was CEO at ABI for seven years and was chairman of the board for six, after which he served as vice president at PerkinElmer.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.